# PYQUVI

NDC: 73289-0089
Generic name: deflazacort
Labeler / Manufacturer: Aucta Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SUSPENSION
Routes: ORAL
Marketing started: 20250630

FDA application: ANDA219417

## Active ingredients

- DEFLAZACORT: 22.75 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"73289-0089"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=73289-0089
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=39854f19-d8be-6438-e063-6394a90a9422